Viewing Study NCT05174832


Ignite Creation Date: 2025-12-24 @ 9:24 PM
Ignite Modification Date: 2025-12-29 @ 6:52 AM
Study NCT ID: NCT05174832
Status: UNKNOWN
Last Update Posted: 2023-09-28
First Post: 2021-12-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Induction of Cisplatin/Nab-paclitaxel/Pembrolizumab Followed by Olaparib/Pembrolizumab Maintenance in mTNBC Patients
Sponsor: Fudan University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module